Connect with us

News

ICAN Unveils New Corporate Logo

Published

on

ICAN-New-Corporate-Logo-Investors King

The Institute of Chartered Accountants of Nigeria (ICAN), a leading umbrella body of the accounting profession in Africa, today unveiled its new corporate logo and visual identity that signifies its leadership, resilience, indelible footprints, growth and dynamism.

Speaking at the unveiling event, tagged The Renaissance Dinner, which held at the Oriental Hotel, Lagos, the President of the Institute, Comfort Olu Eyitayo, said: “Today marks a new beginning as we consolidate the immense contributions of the founding fathers and past presidents of our noble Institute. The accounting profession is dynamic and they have firmly established a lasting legacy: the philosophy of keeping pace with the times.”

She added that “In 56 years, ICAN has sustained its enviable status as the most influential and prestigious professional accountancy institute in Africa. Our unmatched contributions to national development are the unique selling point that has accorded the Institute its enviable position. The ICAN brand is not just the toast of employers, but the products of the Institute are distinguishing themselves across all sectors – public or private.

“Our gathering this evening is to witness the rebirth of ICAN. This rebirth further amplifies what we represent as an Institute: promotion of Accuracy and Integrity and the continuous and conscious drive to act in the public interest. We are here to witness the launch of the Institute into an era of greater dynamism and deeper inclusiveness across generations. We are here to celebrate the new face of ICAN for Greater Visibility and Impact,” she enthused.

The predominant blue colour in the new logo evokes professionalism, trust, reliability, stability, depth, benevolence and vibrancy of ICAN. The green stripe at the bottom represents vitality, freshness, growth and youthfulness while the two white stripes evoke a feeling of dynamism, integrity, transparency and new roads leading to new places and horizons. The new identity in alignment with global trends is modern, innovative and professional. It is designed to work effortlessly across digital and physical channels.

The Special Guest of honour at the unveiling ceremony, Deputy Governor of Lagos State, Dr. Obafemi Hamzat, commended the leadership of ICAN on the rebirth while acknowledging the contributions of the Institute and accounting professionals in national development. According to him, “ICAN is maintaining its leadership in the profession and adapting equally well to the global disruptions, even coming out stronger and youthful.”

With this new beginning, ICAN pledges its unwavering commitment to members and other stakeholders with a greater positive impact on nation-building. The Institute is poised to promote professional excellence, deepen its advocacy and facilitate accountability and transparency across the economy.

Continue Reading
Comments

News

Kanu Appears in Court, Pleads Not Guilty to Seven Count Charges

Published

on

Nnamdi Kanu

Nnamdi Kanu, the leader of the Indigenous People of Biafra, IPOB, earlier today pleaded not guilty to the seven-count amended charge the Federal Government preferred against him.

Kanu, who was docked before trial Justice Binta Nyako, said he was innocent of all the allegations FG levelled against him after the charge was read to him in the open court.

His re-arraignment came on day the Department of State Services, DSS, blatantly refused to allow even a single journalist inside the courtroom.

Though this reporter and six other journalists were initially cleared at the main gate of the court to enter the premises, upon his arrival at the door leading to the courtroom, arm-wielding operatives of the secret service denied him entry.

The operatives insisted their action was based on “order from above”.

Continue Reading

News

Francis Megwa, an Inexperience Nigerian Doctor, Faces Panel in Ireland for Poor Professional Performance

Published

on

malaria treatment

Francis Megwa, an inexperienced Nigerian doctor, described as ‘knowing next to nothing’ by doctors at University Maternity Hospital Limerick (UMHL) is facing the Irish medical panel for poor professional performance.

Dr. Megwa, who was fired by University Maternity Hospital Limerick (UMHL) for lacking basic medical knowledge claims he had always made the hospital authorities aware of his lack of experience.

Dr Francis Megwa told a medical inquiry that the panel who interviewed him for the job of senior house officer (SHO) at UMHL in April 2018 knew about his limitations but he still believed he was expected to improve “in days rather than months”.

A hearing of the Irish Medical Council’s fitness to practise (FTP) committee was informed that Dr Megwa had never worked in a paid role in a hospital since qualifying as a doctor in Romania in 2015.

“This was the level of experience I had before taking up the job which they knew,” Dr Megwa said.

A consultant gynaecologist and obstetrician who interviewed Dr Megwa for his post at UMHL in April 2018, Mendinaro Imcha, admitted the recruitment process could have been better but stated it had improved since the hospital had hired him.

The Nigerian-born doctor, who was placed on call on his first day in the job, is facing two charges of poor professional performance over his time working at UMHL between July 9, 2018, and August 14, 2018.

The IMC claims he failed to demonstrate basic competency in taking a patient’s clinical history, in diagnosing symptoms, inserting cannulas, and in prescribing common medication.

He is also charged with being unable to give a clear history about a pregnant woman who had presented at UMHL with vaginal bleeding or estimate her level of blood loss as well as failing to recommend appropriate treatment for her.

The inquiry heard earlier evidence from witnesses that Dr Megwa knew “near nothing”, was unable to take blood samples, and had to ask what an obstetrician was.

He was accused of incorrectly diagnosing the woman who was 35 weeks pregnant with a condition associated with the first weeks of pregnancy when she was actually suffering from a potential emergency complication.

The inquiry heard Dr Megwa had described working as a SHO with the Royal Infirmary of Edinburgh Scotland because he felt it was the “most appropriate term”.

Dr Imcha said his CV stated he had previous work experience as an SHO and had completed an internship at his medical school in Romania.

He was also registered with the Irish Medical Council (IMC) and had an EU medical qualification.

The FTP committee heard Dr Megwa had been ranked fourth out of five candidates on a panel to fill vacant SHO posts at UMHL.

He had been scored 55 out of 100 for his medical and diagnostic skills, 60 out of 100 for decision-making and initiative, and 70 out of 100 for communication and personal skills.

The interview panel had noted Dr Megwa was “short of experience but eager to work and learn”.

A member of the FTP committee, Veronica Larkin, said there appeared to be “a big mismatch” between the marks scored by Dr Megwa and his subsequent work performance.

Dr Imcha admitted she was “surprised and worried” when she was alerted within a few days of Dr Megwa taking up his post about problems with his performance, although she still wanted to give him a chance.

However, Dr Imcha said a decision was taken to assess the SHO’s competence after she was notified that his performance had not improved and other staff remained concerned about his treatment of patients.

Dr Imcha recalled how Dr Megwa, who had already been given an oral warning, struggled to answer questions based on what a final-year medical student should know, while she was also concerned that he was unable to specify the speciality he had done during his internship.

The consultant said she had made a complaint to the IMC about Dr Megwa as he lacked the basic knowledge expected of someone who had been to medical school for five or six years and completed an internship.

“We felt it may not be safe for him to continue,” she recalled.

Dr Imcha said she was unaware that Dr Megwa complained that he was shaking and panting with nerves during his assessment meeting.

Dr Megwa said he had learnt to take blood and fit cannulas after just a few days working at the hospital but claimed the only people who really helped him at UMHL were his fellow SHOs.

The hearing was adjourned until a future date.

Continue Reading

News

Nigeria, World Bank To Raise $30M For Vaccine Plant — Osinbajo

Published

on

yemi osinbajo

The Vice President of Nigeria, Yemi Osinbajo said the federal government and the World Bank are working together to raise $30 million to fund a vaccine factory in the country.

VP Osinbajo discussed this on Monday in Abuja at the International Conference on “Access to Health and Socio-Economic Development Beyond Covid-19: The First Multisectoral Approach to Finding Solutions.”

The conference was organized by the National Institute for Pharmaceutical Research and Development, NIPRD. He said the global health trend has made it essential for Nigeria to establish its own vaccine production facilities.

“Nigeria is in talks with the private lending arm of the World Bank and other lenders to raise around $30 million to help finance a vaccine factory.

“Bio-vaccine Nigeria Limited is chaired by Professor Oyewale Tomori; 49 percent of the company is owned by the Nigerian government with the remainder held by May and Baker Nigeria PLC and they are planning to start construction of a factory.

“ I believe in the first quarter of next year; the plant which is supposed to be located in Ota, Ogun State, will initially, we are told, fill and finish, which I’m also told, means importing the raw materials for the vaccines and then packaging them for distribution.

“Some South African companies are already involved in this task; I believe Aspen Pharmacare and Belvac Institute operate similar facilities.

“Full manufacturing, we are told, should follow in the months or years to come; I’m not quite sure when.

“So it’s obvious that the way forward is more funding for healthcare and research for innovators to develop solutions in pharmaceuticals and medical consumables.”

The Vice President said that through the discussion he had with NIPRD Director-General Dr. Obi Adigwe, he was inspired by the potential and the kind of support that the pharmaceutical industry and research agencies provided.

Osinbajo said the federal government established the Health Sector Intervention Fund which disbursed 76.9 billion naira, or about $185 million, to finance the acquisition and installation of critical medical care equipment.

He said the fund was also intended for the expansion of production lines at various pharmaceutical companies across the country.

According to him, the Central Bank of Nigeria (CBN) is also supporting a number of research and development initiatives in the health sector, as it has disbursed a total of 233 billion naira in grants.

Mr. Osinbajo said the NIPRD is also making immense contributions to developing a local cure for COVID-19.

“NIPRD has also developed an impressive variety of pharmaceutical products from indigenous resources and both the Niprimune and Niprimune plus both of which I have the pleasure of seeing, have been found to possess a reasonable property that is able to prevent or combat COVID-19.

“Both products, which have been registered by NAFDAC, are currently undergoing clinical studies at various levels with a view to production approval for emergency use.

“NIPRD Director-General Dr. Obi Adigwe assured that around the same time next year, the institute will launch three new products currently under development at its centers for nanomedicine, artificial intelligence and machine learning.

“It is this proactive approach that we must adopt in the face of the slow access to vaccines in Africa and of course in Nigeria.

“Although we have received help from some friendly countries and the Covax alliance, less than 4 percent of our eligible population would have been vaccinated by the end of this year.

“There is no doubt that we cannot afford not to have our own vaccine production facilities.”

He said the COVID-19 pandemic was a revelation for him in five different ways: the unpreparedness of most developed economies; vaccine reluctance and the danger of conspiracy theory and misinformation, especially in a public health crisis.

VP Osinbajo said the fourth revelation was that, in terms of the COVID-19-wide global health crisis, help should not be expected.

“The fifth revelation is that despite infrastructure weaknesses, in Nigeria we have an experienced and robust public health system, populated by some of the best staff in the world.

“But more importantly, we have the opportunity to become one of the leading countries in healthcare,” he said.

Earlier, in his welcoming address, Adigwe said the conference was the first of its kind to bring together multidisciplinary academics to engage, innovate and synthesize new approaches to solving global health challenges.

Keynote speaker Prof Joseph Fortunak, who spoke virtually, said COVID-19 exposed the vulnerability of the pharmaceutical supply chain and urged Nigeria to take drug manufacturing seriously.

Continue Reading




Advertisement
Advertisement
Advertisement

Trending